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INTRODUCTION:  Malignant  peripheral  nerve  sheath  tumors  (MPNSTs)  are  very  rare  soft-tissue  tumors.
These  tumors  originate  from  Schwann  cells  or pluripotent  perineural  cells  of  the  neural  crest.  An  isolated
MPNST  of the  kidney  is extremely  rare  and  has  been  reported  in  only  six  cases  to date.
PRESENTATION OF CASE:  A 30-year-old  female  with  an  unremarkable  past  medical  and  surgical  history
presented  with  an  enlarging,  right-sided  abdominal  mass  for  the  last  3 months.  A CT  scan  of  the  abdomen
and  pelvis  showed  a large  exophytic  mass  arising  from  the  right  kidney.  A metastatic  work-up  was
negative,  so  a  right  radical  nephrectomy  was  performed.  Histopathological  and  immunohistochemical
studies  conﬁrmed  the  diagnosis  of  an MPNST.
DISCUSSION: MPNSTs  are rare  and  aggressive  soft-tissue  sarcomas  that  are usually  associated  with  neu-
roﬁbromatosis  type  1 (NF-1)  but that also  occur  post-radiation  and  sporadically.  These  tumors  are  highly
malignant  neoplasms  with  a  high  recurrence  rate  and  distant  metastases.  Complete  surgical  excision
remains  the  mainstay  of  treatment  due  to  the limited  response  of  MPNSTs  to  both  chemotherapy  and
radiotherapy.
CONCLUSION:  MPNSTs  arising  from  the  kidney  are very  rare.  Complete  surgical  resection  provides  the
only  hope  for  cure.  Postoperative  chemotherapy  and  radiotherapy  are  still  controversial,  although  post-
operative  radiotherapy  is currently  recommended  by an  oncology  consensus  group.
© 2013 The Author. Published by Elsevier Ltd on behalf of Surgical Associates Ltd. . Introduction
Malignant peripheral nerve sheath tumors (MPNSTs) are rare
oft-tissue sarcomas that commonly occur in the extremities and
re often associated with neuroﬁbromatosis. MPNSTs accounts for
–10% of all soft-tissue sarcomas, and up to 50% occur in patients
ith neuroﬁbromatosis type 1 (NF-1), 10% are radiation-induced,
nd 40% are sporadic.2 MPNSTs affect adults aged 20–50 years
nd are typically connected to the main trunks of nerves. Most
PNSTs are aggressive and have high rates of recurrence and dis-
ant metastases, with the lungs being the most common site of
PNST metastases. An MPNST of the kidney is an exceedingly rare
ccurrence.4 An aggressive surgical approach, when feasible, is con-
idered to be the treatment of choice.. Case presentation
A 30-year-old female patient not known to have any medical
llnesses presented with a dull, constant pain and an enlarging
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ttp://dx.doi.org/10.1016/j.ijscr.2013.07.013mass in the right side of her abdomen for the last 3 months. The
mass was  associated with backache and nausea. Upon examina-
tion, a large abdominal mass of ﬁrm consistency and occupying
the upper and lower right quadrants was  identiﬁed. The vital
signs were normal, and there was  no icterus or pallor. A blood
analysis showed a hemoglobin (Hb) level of 13.1 g/dL. The total
bilirubin; renal proﬁle; and alkaline phosphatase, serum albumin,
serum urea and electrolyte levels were normal. Testing for anti-
bodies against hepatitis C virus (anti-HCV) was  negative. A CT
scan and MRI  of the abdomen (Fig. 1) revealed a large, encapsu-
lated exophytic mass involving the medial aspect of the kidney,
which was  displaced inferolaterally. The mass extended beyond
Gerota’s fascia and caused a mass effect on adjacent organs, dis-
placing the liver dome superiorly; the hepatic ﬂexure inferiorly;
and the gallbladder, duodenum and pancreas medially. However,
there was  no deﬁnite invasion of adjacent organs. The mass mea-
sured approximately 14.5 cm × 19.0 cm and encased the right renal
artery. The right renal vein and IVC were severely compressed by
the mass; however, there was  no deﬁnite invasion. The growth was
surrounded by parasitic vessels but no enlarged regional lymph
nodes. The post-contrast images showed gradual enhancement of
the mass. The liver showed a normal contour and signal intensity
and four hemangiomas, with the largest in segment VIII, measuring
Open access under CC BY license.4.7 cm × 5.1 cm. There were two simple hepatic cysts in segment
VIII.
A right radical nephrectomy was  performed. The operation
went smoothly, with no major blood loss. The post-operative
 Ltd. Open access under CC BY license.
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gig. 1. CT (A) and MRI  (B) showing a large right kidney tumor (T) arising from the m
nd  four hemangiomas, with the largest (H) in segment VIII, measuring 4.7 cm × 5.1
ecovery was uneventful. Histopathology of the resected
ass revealed a right nephrectomy specimen measuring
4.0 cm × 15.0 cm × 10.0 cm and weighing 3.0 kg. The right adrenal
land had unremarkable histology. The right kidney was  involved
nd inﬁltrated by a neuroﬁbrosarcomatous tumor consistent with
n MPNST. High-grade features were observed, including a high
itotic rate and necrosis. The tumor invaded the renal capsule
o Gerota’s fascia. Renal pelvis invasion was present. No vascular
nvasion was noted. Ureteric, vascular and all surgical resection
argins were free of malignancy. The case was  discussed by
 combined tumor board, and postoperative radiotherapy was
ecommended. Six months after the operation, the patient is still
oing well, and a contrast-enhanced CT scan did not reveal any
ecurrence of the tumor (Fig. 2).
ig. 2. CT scan follow-up 6 months after surgery, with no recurrence or residual
umor and no evidence of distant metastasis. Stable appearance of multiple heman-
iomas of the liver (arrow) with no interval development of new hepatic lesions. aspect of the right kidney. The liver showed a normal contour and signal intensity
3. Discussion
MPNSTs are rare and highly aggressive soft-tissue sarcomas
that are associated with neuroﬁbromas in NF-1 patients but that
also occur in association with radiation or sporadically. Patient
with NF-1 usually present with multiple rapidly enlarging masses
or a new onset of pain associated with pre-existing plexiform
neuroﬁbromas, whereas the sporadic forms present with a new
solitary, enlarging and painless mass.2 The extremities are most
common sites for MPNSTs, followed by the head and neck region
and the trunk. Kidney involvement is uncommon, and it is very
difﬁcult to differentiate other kidney sarcomas from MPNSTs clin-
ically or upon gross examination.5 Thus, histopathological and
immunohistochemical studies are needed for the diagnosis and
grading of an MPNST.3 Grossly, MPNSTs appear fusiform, have
a large tumor size (>5 cm)  and are gray-tan in color. Micro-
scopically, these tumors exhibit features of spindle cells, with a
fascicular pattern and varying degrees of mitosis, necrosis and
tumor calciﬁcation. Associated benign neuroﬁbroma or schwan-
nanian cells that have not undergone malignant transformation
can be observed. MPNSTs stain positive for S-100 protein; neuron-
speciﬁc enolase; and other proteins, such as actin, cytokeratin (CK),
smooth muscle actin (SMA), desmin and vimentin, to differen-
tiate from other spindle cell sarcomas.6 CT and MRI  are helpful
imaging techniques for identifying the tumor extent and may
suggest the tumor’s origin. The presence of heterogeneity, necro-
sis and hemorrhage in MRI  and increased uptake on a positron
emission tomography scan may  help to detect malignant change.1
Tumor size, local recurrence and the completeness of surgical
resection are the most important prognostic factors for MPNSTs.
Complete surgical resection is the treatment of choice for MPN-
STs and provides the only hope for cure. MPNSTs are considered
to be chemotherapy- and radiotherapy-resistant tumors. However,
postoperative radiotherapy has a deﬁnite role in both disease-free
and overall survival and is currently recommended by an oncology
consensus group.7 Despite multimodal therapy, including aggres-
sive surgical resection and adjuvant radiotherapy, the prognosis
remains poor.4. Conclusions
MPNSTs of the kidney are rare malignant tumors. Wide local
excision, if feasible, is considered to be the preferred approach
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ecause the prognosis is largely dependent on the completeness
f surgical resection. Postoperative radiotherapy is recommended.
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